专利号:WO-2011130852-A1 优先权日:2010-04-21 标题:Preparation of intermediates for the synthesis of dihydropyridine calcium channel blockers 发明人:SOUZA FABIO; PAN MING 权利人:ALPHORA RES INC; SOUZA FABIO; PAN MING 摘要:4- (2,3- dichlorophenyl) -1,4- dihydro- 2,6- dimethyl- 5- methoxycarbonyl- 3- pyridinecarboxylic acid, a key intermediate in the synthesis of the cardiovascular calcium channel blocker drug 3-butanoyloxymethoxycarbonyl-5- methoxycarbonyl-4- (2,3-dichlorophenyl) -2,6- dimethyl-1,4- dihydropyridine, of purity greater than 97% and essentially free of the corresponding diacid, is prepared by a process involving selective precipitation of its carboxylate via addition of concentrated solutions of alkali metal salts. Similar intermediate mono-carboxylic acids useful in the synthesis of other unsymmetrically substituted dihydropyrine drugs such as nisoldipine, nitrendipine and nimodipine can be similarly prepared and purified.
专利号:US-2023091651-A1 优先权日:2021-09-20 标 题:Dietary supplement and method for synthesis of same 发明人:WYNN JASON R 权利人:StrongCell LLC 摘要:A dietary supplement and method for synthesis of the same are disclosed. In one embodiment of the method, an NADH component is provided that includes at least partially microencapsulated nicotinamide having nicotinamide blended with water. A supplement component, such as collagen, coenzyme Q10, vitamins, and minerals, is provided. A mixed component, which is a liquid, is formed by mixing the NADH component with the supplement component at ambient conditions. The mixed component is subjected to a fill production process.
专利号:US-2023089537-A1 优先权日:2021-09-20 标题:Dietary supplement and method for synthesis of same 发明人:WYNN JASON R 权利人:StrongCell LLC 摘要:A dietary supplement and method for synthesis of the same are disclosed. In one embodiment of the method, an NADH component is provided which includes NADH from about 0.1% to about 0.5% blended with water from about 40% to about 84% both by weight of the dietary supplement. A supplement component from about 9% to about 99% by weight of the dietary supplement is also provided. The supplement component may include collagen in about 2% to about 10%, vitamins in about 0.00001% to about 3%, and minerals in about 0.000002% to about 0.5% all by weight of the dietary supplement. A mixed component is formed by mixing the NADH component with the supplement component at ambient conditions. The mixed component is a liquid at ambient conditions having a pH of less than 4.0. The mixed component is subjected to a cold fill production process.
专利号:US-2013150622-A1 优先权日:2011-12-12 标题:Stereoselective synthesis of tapentadol and its salts 发明人:FANDRICK DANIEL ROBERT; RODRIGUEZ SONIA; YANG BING-SHIOU 权利人:BOEHRINGER INGELHEIM INT; BOEHRINGER INGELHEIM INT 摘要:A process for the synthesis of a salt of tapentadol.
专利号:US-10604479-B2 优先权日:2013-11-18 标 题:Continuous process for the one-pot synthesis of metal salts and metal complexes 发明人:LEONARDI GIULIANO; GASPERONI GIOVANNI 权利人:VOLARE & CONNECTING LLC; LEONARDI GIULIANO; NOVUS INT INC 摘要:A continuous process is described for the one-pot synthesis of compounds, such as metal salts and metal complexes, as well as optionally for the protection of the compounds thus obtained by coating and/or impregnation with suitable compounds.
专利号:US-5002641-A 优先权日:1990-06-28 标题:Electrochemical synthesis of niacin and other N-heterocyclic compounds 发明人:TOOMEY JR JOSEPH E 权利人:REILLY IND INC 摘要:An electrochemical oxidation of a pi-deficient N-heterocyclic precursor compound having an oxidizable organic group attached by a carbon-to-carbon linkage. This precursor compound is at least sparingly water soluble. The preferred electro-oxidation is conducted at an effective anode and in a medium which consists essentially of water, carboxylic acid, and the precursor compound. Preferred are electro-oxidations of substituted pyridine and quinoline bases and a particularly preferred aspect provides a convenient electrochemical synthesis of niacin from 3-methylpyridine.
[参考文献]: Kang Cheng, Et Al. Antagonism Of The Prostaglandin D2 Receptor 1 Suppresses Nicotinic Acid-Induced Vasodilation In Mice And Humans. Proc Natl Acad Sci U S A. 2006 Apr 25;103(17):6682-7. [参考文献]: Areeg M Almubarak, Et Al. Supplementation With Niacin During In Vitro Maturation Improves The Quality Of Porcine Embryos. Theriogenology. 2021 Jul 15;169:36-46. Doi: 10.1016/j.Theriogenology.2021.04.005. Epub 2021 Apr 18. [参考文献]: Bruckert E, Et Al. Meta-Analysis Of The Effect Of Nicotinic Acid Alone Or In Combination On Cardiovascular Events And Atherosclerosis. Atherosclerosis. 2010 Jun;210(2):353-61. [参考文献]: Ishii N, Et Al. Pellagra Among Chronic Alcoholics: Clinical And Pathological Study Of 20 Necropsy Cases. J Neurol Neurosurg Psychiatry. 1981 Mar;44(3):209-15. [参考文献]: Nobuhiro Hirakawa, Et Al. Anti-Invasive Activity Of Niacin And Trigonelline Against Cancer Cells. Biosci Biotechnol Biochem. 2005 Mar;69(3):653-8.
合成参考文献
参考文献:10.2174/157488410791110760 摘要:Nakajima K. Pharmacotherapy of mixed dyslipidemia in the metabolic syndrome. Curr Clin Pharmacol. 2010 May;5(2):133–9. doi: 10.2174/157488410791110760. 参考文献:10.18632/aging.100052 摘要:Altmeyer M, Hottiger MO. Poly(ADP-ribose) polymerase 1 at the crossroad of metabolic stress and inflammation in aging. Aging (Albany NY). 2009 May 20;1(5):458–69. 参考文献:10.18632/aging.100071 摘要:Rozing MP, Westendorp RG, Frölich M, de Craen AJ, Beekman M, Heijmans BT, Mooijaart SP, Blauw GJ, Slagboom PE, van Heemst D; Leiden Longevity Study (LLS) Group. Human insulin/IGF-1 and familial longevity at middle age. Aging (Albany NY). 2009 Jul 24;1(8):714–22. 参考文献:10.2165/11319380-000000000-00000 摘要:Chatzizisis YS, Koskinas KC, Misirli G, Vaklavas C, Hatzitolios A, Giannoglou GD. Risk factors and drug interactions predisposing to statin-induced myopathy: implications for risk assessment, prevention and treatment. Drug Saf. 2010 Mar 01;33(3):171–87. doi: 10.2165/11319380-000000000-00000. 参考文献:10.1111/j.1462-2920.2010.02166.x 摘要:Molina‐Henares MA, De La Torre J, García‐Salamanca A, Molina‐Henares AJ, Herrera MC, Ramos JL, Duque E. Identification of conditionally essential genes for growth of Pseudomonas putida KT2440 on minimal medium through the screening of a genome‐wide mutant library. Environmental Microbiology. 2010 Jun;12(6):1468–85. doi: 10.1111/j.1462-2920.2010.02166.x.